Cargando…
Inhibition of the mRNA-Binding Protein IGF2BP1 Suppresses Proliferation and Sensitizes Neuroblastoma Cells to Chemotherapeutic Agents
Gain at chromosome 17q21 in neuroblastoma is associated with a poor prognosis, independent of MYCN amplification status. Several potential proto-oncogenes have been identified in this region, one of them—insulin-like growth-factor-2 mRNA binding protein (IGF2BP1)—is expressed at high levels in stage...
Autores principales: | Biegel, Jason M., Dhamdhere, Mayura, Gao, Shuang, Gowda, Chethana P., Kawasawa, Yuka Imamura, Spiegelman, Vladimir S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008117/ https://www.ncbi.nlm.nih.gov/pubmed/33796454 http://dx.doi.org/10.3389/fonc.2021.608816 |
Ejemplares similares
-
Global role of IGF2BP1 in controlling the expression of Wnt/β-catenin-regulated genes in colorectal cancer cells
por: Singh, Vikash, et al.
Publicado: (2023) -
Extracellular vesicle-dependent effect of RNA-binding protein IGF2BP1 on melanoma metastasis
por: Ghoshal, Archita, et al.
Publicado: (2019) -
Generation of Novel Immunocompetent Mouse Cell Lines to Model Experimental Metastasis of High-Risk Neuroblastoma
por: Dhamdhere, Mayura R., et al.
Publicado: (2023) -
IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment
por: Elcheva, Irina A., et al.
Publicado: (2023) -
RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1.
por: Elcheva, Irina A., et al.
Publicado: (2019)